“I’m honored to lead CDER at a time when the F.D.A. is achieving long-sought regulatory reforms,” Dr. Pazdur said in an agency news release on Tuesday. He said he was looking forward to helping “our country reach its peak in drug development.”

In recent weeks, federal officials accepte

📰

Continue Reading on New York Times

This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.

Read Full Article →